Epilepsy

Epilepsy Treatment Often Delayed in Older Adults

Epilepsy Treatment Often Delayed in Older Adults

By

Despite recommendations, many patients in the cohort were prescribed older antiepileptic drugs.

Addressing Comorbid Depression in Epilepsy: Challenges in Diagnosis and Treatment

Addressing Comorbid Depression in Epilepsy: Challenges in Diagnosis and Treatment

By

There are several drug-based and non-pharmacological treatments available that can help reduce symptoms of depression in patients with epilepsy.

Epilepsy Education Group Helps Patients Cope With Isolation, Anger

Epilepsy Education Group Helps Patients Cope With Isolation, Anger

By

Patients who participated in a group course with other people with epilepsy felt less isolated and more confident.

Maternal Antiepileptic Use and Risk for Major Congenital Malformations in Offspring

Maternal Antiepileptic Use and Risk for Major Congenital Malformations in Offspring

By

A diagnosis of maternal epilepsy alone was not associated with an increase in congenital malformations in offspring.

Quality Improvement Measures Improve Health Care Utilization in Epilepsy

Quality Improvement Measures Improve Health Care Utilization in Epilepsy

Quality improvement measures help to reduce emergency department visits, inpatient hospitalizations, and health care claims.

Epileptic Seizures in Multiple Sclerosis May Suggest Shared Pathology

Epileptic Seizures in Multiple Sclerosis May Suggest Shared Pathology

By

Patients with both MS and epileptic seizures had a younger age at onset of MS compared with those without seizures.

Guidelines for Using fMRI for Presurgical Evaluation of Epilepsy

Guidelines for Using fMRI for Presurgical Evaluation of Epilepsy

By

Functional MRI may provide a less-invasive option for evaluating memory function in patients undergoing epilepsy surgery.

Should EEG Periodic Discharges be Managed Similarly to Seizures?

Should EEG Periodic Discharges be Managed Similarly to Seizures?

By

Brain oxygenation may be compromised during periodic discharges, ultimately warranting treatment.

Seizure Reduction Likely With Surgery in Nonlesional Neocortical Epilepsy

Seizure Reduction Likely With Surgery in Nonlesional Neocortical Epilepsy

By

Nearly 60% of patients had achieved seizure freedom at last follow-up, 10 to 21 years after surgery.

EEG Patterns in Critically Ill Point to Greater Risk of Seizures

EEG Patterns in Critically Ill Point to Greater Risk of Seizures

By

Careful monitoring of EEG patterns is a useful way to stratify seizure risk in critically ill patients.

First-Line Treatment With Carbamazepine in Neonatal Epilepsy

First-Line Treatment With Carbamazepine in Neonatal Epilepsy

By

The results confirm the effectiveness and safety of low-dose CBZ as a first-line agent for the treatment of neonatal seizures.

Vigabatrin Plus Hormonal Therapy Superior in Infantile Spasms

Vigabatrin Plus Hormonal Therapy Superior in Infantile Spasms

By

Greater spasm cessation was achieved in the combination group vs those who received hormonal therapy alone.

VIDEO: Identifying Risk Factors for Post-Stroke Epilepsy

VIDEO: Identifying Risk Factors for Post-Stroke Epilepsy

By

Beate Diehl, MD, PhD, FRCP, discusses her research on post-stroke epilepsy.

VIDEO: Gap in Provider Knowledge Delays Diagnosis, Treatment of Infantile Spasms

VIDEO: Gap in Provider Knowledge Delays Diagnosis, Treatment of Infantile Spasms

By

Shaun Hussain, MD, MS, discusses a gap in health care provider knowledge that may contribute to the delay in the diagnosis and treatment of infantile spasms.

VIDEO: Elizabeth Thiele, MD, PhD Discusses Latest Cannabidiol Research

VIDEO: Elizabeth Thiele, MD, PhD Discusses Latest Cannabidiol Research

By

Elizabeth Thiele, MD, PhD discusses results from her research on cannabidiol in Lennox-Gastaut syndrome.

Significant Drug-Drug Interactions With Cannabidiol and Antiepileptics

Significant Drug-Drug Interactions With Cannabidiol and Antiepileptics

By

Clobazam had been previously identified as an AED with a significant interaction with CBD.

VIDEO — Industry Update: Justin Gover, CEO, GW Pharmaceuticals on Epidiolex Status

VIDEO — Industry Update: Justin Gover, CEO, GW Pharmaceuticals on Epidiolex Status

By

Justin Gover, CEO of GW Pharmaceuticals, the parent company of Greenwich Biosciences, discusses the status of the company's cannabidiol product Epidiolex on the heels of positive results from several placebo-controlled trials in epileptic syndromes.

Social Support a Significant Factor in Development of Anxiety, Depression in Epilepsy

Social Support a Significant Factor in Development of Anxiety, Depression in Epilepsy

By

Number of AEDs and seizure frequency also influenced depression in people with epilepsy.

Accurate Surgical Localization Using Combined Imaging Approach in Epilepsy

Accurate Surgical Localization Using Combined Imaging Approach in Epilepsy

By

Concordant EEG/fMRI and ESI predicted outcomes with 100% sensitivity and specificity.

Factors Predictive of Everolimus Efficacy in Tuberous Sclerosis Complex

Factors Predictive of Everolimus Efficacy in Tuberous Sclerosis Complex

By

Adjunctive everolimus treatment has been found to significantly reduce frequency of treatment-resistant seizures in TSC.

A Novel Risk Score for Seizures After Stroke

A Novel Risk Score for Seizures After Stroke

By

The triple-validated SeLECT score may help identify patients suited for antiepileptic drug trials.

Cannabidiol Reduces Seizure Frequency in Refractory Dravet Syndrome

Cannabidiol Reduces Seizure Frequency in Refractory Dravet Syndrome

By

Results of the phase 3, placebo-controlled trial support previous findings from an expanded-access program.

Brain Atrophy May Help Predict Surgical Outcomes in Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis

Brain Atrophy May Help Predict Surgical Outcomes in Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis

By

Atrophy in areas outside of the MTLE-HS network may predict poor surgical outcomes.

Major Provider Knowledge Gap Delays Diagnosis, Treatment of Infantile Spasms

Major Provider Knowledge Gap Delays Diagnosis, Treatment of Infantile Spasms

By

Less than 30% of patients were seen by an effective provider within 1 week of onset of infantile spasms.

Potential Reduction in Seizure Frequency With Statin Therapy

Potential Reduction in Seizure Frequency With Statin Therapy

By

Half of patients experienced a reduction in seizure frequency after statin initiation.

Polypharmacy Alone Worsens Quality of Life in Epilepsy

Polypharmacy Alone Worsens Quality of Life in Epilepsy

By

Awareness of the effects of polypharmacy on patient well-being is an important component of care.

Cannabidiol Helps Reduce Frequency of Drop Seizures in Lennox-Gastaut Syndrome

Cannabidiol Helps Reduce Frequency of Drop Seizures in Lennox-Gastaut Syndrome

By

Patients taking cannabidiol experienced a significant reduction in drop seizures compared with placebo.

Age, Lesion Volume Influence Epilepsy Risk After Stroke

Age, Lesion Volume Influence Epilepsy Risk After Stroke

By

Patients with lesions in the left basal ganglia were more likely to have post-stroke epilepsy.

What to Expect at the 2016 American Epilepsy Society Annual Meeting

What to Expect at the 2016 American Epilepsy Society Annual Meeting

By

Michael Privatera, MD, AES president spoke with Neurology Advisor about some of the key topics and presentations slated for this year's meeting.

Increased Physical, Mental Comorbidity in Veterans With Epilepsy

Increased Physical, Mental Comorbidity in Veterans With Epilepsy

By

Veterans with epilepsy could benefit from evidence-based chronic disease self-management programs that target physical and psychiatric comorbidities.

Sign Up for Free e-newsletters